S&P 500   5,132.59 (+0.71%)
DOW   39,067.34 (+0.18%)
QQQ   445.26 (+1.43%)
AAPL   178.68 (-1.15%)
MSFT   414.89 (+0.30%)
META   502.43 (+2.51%)
GOOGL   138.18 (-0.20%)
AMZN   178.38 (+0.92%)
TSLA   204.03 (+1.06%)
NVDA   817.60 (+3.35%)
NIO   5.83 (+1.39%)
AMD   200.73 (+4.26%)
BABA   74.84 (+1.09%)
T   16.98 (+0.30%)
F   12.44 (+0.00%)
MU   95.91 (+5.85%)
CGC   3.25 (-1.22%)
GE   159.10 (+1.41%)
DIS   112.05 (+0.42%)
AMC   4.40 (+1.85%)
PFE   26.56 (+0.00%)
PYPL   60.62 (+0.46%)
XOM   105.80 (+1.22%)
S&P 500   5,132.59 (+0.71%)
DOW   39,067.34 (+0.18%)
QQQ   445.26 (+1.43%)
AAPL   178.68 (-1.15%)
MSFT   414.89 (+0.30%)
META   502.43 (+2.51%)
GOOGL   138.18 (-0.20%)
AMZN   178.38 (+0.92%)
TSLA   204.03 (+1.06%)
NVDA   817.60 (+3.35%)
NIO   5.83 (+1.39%)
AMD   200.73 (+4.26%)
BABA   74.84 (+1.09%)
T   16.98 (+0.30%)
F   12.44 (+0.00%)
MU   95.91 (+5.85%)
CGC   3.25 (-1.22%)
GE   159.10 (+1.41%)
DIS   112.05 (+0.42%)
AMC   4.40 (+1.85%)
PFE   26.56 (+0.00%)
PYPL   60.62 (+0.46%)
XOM   105.80 (+1.22%)
S&P 500   5,132.59 (+0.71%)
DOW   39,067.34 (+0.18%)
QQQ   445.26 (+1.43%)
AAPL   178.68 (-1.15%)
MSFT   414.89 (+0.30%)
META   502.43 (+2.51%)
GOOGL   138.18 (-0.20%)
AMZN   178.38 (+0.92%)
TSLA   204.03 (+1.06%)
NVDA   817.60 (+3.35%)
NIO   5.83 (+1.39%)
AMD   200.73 (+4.26%)
BABA   74.84 (+1.09%)
T   16.98 (+0.30%)
F   12.44 (+0.00%)
MU   95.91 (+5.85%)
CGC   3.25 (-1.22%)
GE   159.10 (+1.41%)
DIS   112.05 (+0.42%)
AMC   4.40 (+1.85%)
PFE   26.56 (+0.00%)
PYPL   60.62 (+0.46%)
XOM   105.80 (+1.22%)
S&P 500   5,132.59 (+0.71%)
DOW   39,067.34 (+0.18%)
QQQ   445.26 (+1.43%)
AAPL   178.68 (-1.15%)
MSFT   414.89 (+0.30%)
META   502.43 (+2.51%)
GOOGL   138.18 (-0.20%)
AMZN   178.38 (+0.92%)
TSLA   204.03 (+1.06%)
NVDA   817.60 (+3.35%)
NIO   5.83 (+1.39%)
AMD   200.73 (+4.26%)
BABA   74.84 (+1.09%)
T   16.98 (+0.30%)
F   12.44 (+0.00%)
MU   95.91 (+5.85%)
CGC   3.25 (-1.22%)
GE   159.10 (+1.41%)
DIS   112.05 (+0.42%)
AMC   4.40 (+1.85%)
PFE   26.56 (+0.00%)
PYPL   60.62 (+0.46%)
XOM   105.80 (+1.22%)
NYSE:MLSS

Milestone Scientific (MLSS) Stock Price, News & Analysis

$0.73
+0.02 (+3.30%)
(As of 01:32 PM ET)
Today's Range
$0.72
$0.75
50-Day Range
$0.57
$0.72
52-Week Range
$0.52
$1.35
Volume
151,093 shs
Average Volume
79,050 shs
Market Capitalization
$51.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

MLSS stock logo

About Milestone Scientific Stock (NYSE:MLSS)

Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. The company also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. In addition, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Further, the company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.

MLSS Stock Price History

MLSS Stock News Headlines

Revolutionary Device Redefines Cancer Detection
Discover the breakthrough device that could transform the lives of the estimated 68 million Americans affected by skin cancer. Achieving unprecedented accuracy, this device identifies cancer's molecular signature in just 1.5 seconds. This innovation marks a rapid advance in the battle against cancer. See how investors are unlocking 10% in bonus shares for a limited time.
Revolutionary Device Redefines Cancer Detection
Discover the breakthrough device that could transform the lives of the estimated 68 million Americans affected by skin cancer. Achieving unprecedented accuracy, this device identifies cancer's molecular signature in just 1.5 seconds. This innovation marks a rapid advance in the battle against cancer. See how investors are unlocking 10% in bonus shares for a limited time.
Milestone Scientific Inc. (MLSS)
See More Headlines
Receive MLSS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Milestone Scientific and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/15/2023
Today
3/01/2024
Next Earnings (Estimated)
3/29/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
N/A
Employees
20
Year Founded
N/A

Profitability

Net Income
$-8,710,000.00
Pretax Margin
-71.49%

Debt

Sales & Book Value

Annual Sales
$9.81 million
Book Value
$0.15 per share

Miscellaneous

Free Float
53,144,000
Market Cap
$51.87 million
Optionable
Optionable
Beta
0.93

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Mr. Jan Adriaan Haverhals (Age 62)
    President, CEO & Director
    Comp: $624.76k
  • Mr. Leonard A. Osser (Age 77)
    Founder, MD of China Operations & Director
  • Mr. Andy Molnar (Age 62)
    Senior Vice President of Global Sales & Business Development for Dental
  • Keisha Harcum
    Controller














MLSS Stock Analysis - Frequently Asked Questions

How have MLSS shares performed in 2024?

Milestone Scientific's stock was trading at $0.6899 at the start of the year. Since then, MLSS shares have increased by 3.7% and is now trading at $0.7151.
View the best growth stocks for 2024 here
.

When is Milestone Scientific's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, March 29th 2024.
View our MLSS earnings forecast
.

How were Milestone Scientific's earnings last quarter?

Milestone Scientific Inc. (NYSE:MLSS) announced its earnings results on Tuesday, August, 15th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.02) by $0.01. The business earned $2.91 million during the quarter. Milestone Scientific had a negative trailing twelve-month return on equity of 82.04% and a negative net margin of 71.00%.

What other stocks do shareholders of Milestone Scientific own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Milestone Scientific investors own include AcelRx Pharmaceuticals (ACRX), Aptinyx (APTX), Axcella Health (AXLA), Aytu BioPharma (AYTU), Calithera Biosciences (CALA), Cidara Therapeutics (CDTX), Catalyst Pharmaceuticals (CPRX), DURECT (DRRX), Geron (GERN) and

Who are Milestone Scientific's major shareholders?

Milestone Scientific's stock is owned by many different institutional and retail investors. Top institutional shareholders include Carnegie Capital Asset Management LLC (0.16%), Citadel Advisors LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Leonard Osser, Leslie Bernhard and Neal I Goldman.
View institutional ownership trends
.

How do I buy shares of Milestone Scientific?

Shares of MLSS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:MLSS) was last updated on 3/1/2024 by MarketBeat.com Staff